Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine Dosing Schedules in Chinese Patients with MDS
NCT01751867Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Janssen Pharmaceutical. Started Aug 2009; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01751867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751867.